{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:47:34Z","timestamp":1794048454514,"version":"4.8.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.expneurol.2014.03.010","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T17:54:03Z","timestamp":1396029243000},"page":"44-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":174,"special_numbering":"C","title":["Sex differences in Parkinson's disease and other movement disorders"],"prefix":"10.1016","volume":"259","author":[{"given":"Kara M.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Dahodwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2014.03.010_bb0010","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.neuropharm.2011.04.031","article-title":"Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease","volume":"61","author":"Al-Sweidi","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.neuroscience.2004.09.033","article-title":"Effects of neonatal and prepubertal hormonal manipulations upon estrogen neuroprotection of the nigrostriatal dopaminergic system within female and male mice","volume":"130","author":"Anderson","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0005","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.parkreldis.2011.07.007","article-title":"A randomized pilot trial of estrogen replacement therapy in post-menopausal women with Parkinson's disease","volume":"17","author":"Anon","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2014.03.010_bb9000","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0006-8993(00)02511-7","article-title":"Estrogen modulates responses of striatal dopamine neurons to MPP(+): evaluations using in vitro and in vivo techniques","volume":"872","author":"Arvin","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0020","first-page":"1","article-title":"Prospective study of caffeine consumption and risk of Parkinson's disease in men and women","author":"Ascherio","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0025","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/aje\/kwh312","article-title":"Coffee consumption, gender, and Parkinson's disease mortality in the Cancer Prevention Study II Cohort: the modifying effects of estrogen","volume":"160","author":"Ascherio","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0030","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1212\/01.WNL.0000046523.05125.87","article-title":"Caffeine, postmenopausal estrogen, and risk of Parkinson's disease","volume":"60","author":"Ascherio","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0035","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/WNL.55.9.1358","article-title":"Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging","volume":"55","author":"Baldereschi","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0040","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.lfs.2011.03.010","article-title":"The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson's disease","volume":"88","author":"Baraka","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0050","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1523\/JNEUROSCI.11-05-01325.1991","article-title":"Dopamine content and metabolism in mesencephalic and diencephalic cell cultures: sex differences and effects of sex steroids","volume":"11","author":"Beyer","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0055","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/hmg\/ddn159","article-title":"Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males","volume":"17","author":"Bode","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12066","article-title":"The implication of neuroactive steroids in Tourette syndrome pathogenesis: a role for 5alpha-reductase?","author":"Bortolato","year":"2013","journal-title":"J. Neuroendocrinol"},{"key":"10.1016\/j.expneurol.2014.03.010_bb9990","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.bcp.2007.07.009","article-title":"Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity","volume":"74","author":"Bourque","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0065","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.yfrne.2009.04.014","article-title":"Neuroprotective actions of sex steroids in Parkinson's disease","volume":"30","author":"Bourque","year":"2009","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0070","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1289\/ehp.8095","article-title":"Pesticides and Parkinson's disease\u2014is there a link?","volume":"114","author":"Brown","year":"2006","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/1098-2396(20000915)37:4<245::AID-SYN1>3.0.CO;2-5","article-title":"Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice","volume":"37","author":"Callier","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2014.03.010_bb9980","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/syn.1067","article-title":"Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl\/6 mice","volume":"41","author":"Callier","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0080","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1365-2826.2012.02348.x","article-title":"GDNF contributes to oestrogen-mediated protection of midbrain dopaminergic neurones","volume":"24","author":"Campos","year":"2012","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0085","first-page":"1","article-title":"Effects of gender on nigral gene expression and Parkinson disease","author":"Cantuti-Castelvetri","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0090","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nn922","article-title":"Sex chromosome genes directly affect brain sexual differentiation","volume":"5","author":"Carruth","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0095","first-page":"1","article-title":"Reproductive factors and clinical features of Parkinson's disease","author":"Cereda","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0100","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1460-9568.2009.06610.x","article-title":"X chromosome number causes sex differences in gene expression in adult mouse striatum","volume":"29","author":"Chen","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2014.03.010_bb9970","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s11064-011-0428-z","article-title":"Effect of different doses of estrogen on the nigrostriatal dopaminergic system in two 6-hydroxydopamine-induced lesion models of Parkinson's disease","volume":"36","author":"Cordellini","year":"2011","journal-title":"Neurochem Res"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0105","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archneur.61.6.886","article-title":"Postmenopausal estrogen use affects risk for Parkinson disease","volume":"61","author":"Currie","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1471-4159.2012.07782.x","article-title":"The human testis-determining factor SRY localizes in midbrain dopamine neurons and regulates multiple components of catecholamine synthesis and metabolism","volume":"122","author":"Czech","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2014.03.010_bb9750","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/syn.10145","article-title":"Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice","volume":"47","author":"D'Astous","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2014.03.010_bb9960","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.neuropharm.2004.08.020","article-title":"Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist","volume":"47","author":"D'Astous","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2014.03.010_bb9450","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000079664","article-title":"Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol","volume":"79","author":"D'Astous","year":"2004","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.expneurol.2014.03.010_bb9650","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000091206","article-title":"Differential protective properties of estradiol and tamoxifen against methamphetamine-induced nigrostriatal dopaminergic toxicity in mice","volume":"82","author":"D'Astous","year":"2005","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.expneurol.2014.03.010_bb9550","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jnr.20412","article-title":"Regulation of striatal preproenkephalin mRNA levels in MPTP-lesioned mice treated with estradiol","volume":"80","author":"D'Astous","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.expneurol.2014.03.010_bb9950","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0006-8993(02)02482-4","article-title":"17 beta-estradiol treatment retards excitotoxic delayed degeneration in substantia nigra reticulata neurons","volume":"936","author":"DeGiorgio","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0115","first-page":"1","article-title":"Sexually dimorphic gene expression in mouse brain precedes gonadal differentiation","author":"Dewing","year":"2003","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0120","first-page":"1","article-title":"Direct regulation of adult brain function by the male-specific factor SRY","author":"Dewing","year":"2006","journal-title":"Curr. Biol."},{"key":"10.1016\/j.expneurol.2014.03.010_bb9940","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0006-8993(00)02329-5","article-title":"Estrogen reduces acute striatal dopamine responses in vivo to the neurotoxin MPP+ in female, but not male rats","volume":"868","author":"Disshon","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0135","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0892-0362(96)00086-4","article-title":"Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57\/B1 mice","volume":"18","author":"Dluzen","year":"1996","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.expneurol.2014.03.010_bb9930","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0006-8993(97)00630-6","article-title":"Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine","volume":"767","author":"Dluzen","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0130","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.1365-2826.2001.00675.x","article-title":"Tamoxifen diminishes methamphetamine-induced striatal dopamine depletion in intact female and male mice","volume":"13","author":"Dluzen","year":"2001","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0892-0362(02)00187-3","article-title":"Methamphetamine-gonadal steroid hormonal interactions: effects upon acute toxicity and striatal dopamine concentrations","volume":"24","author":"Dluzen","year":"2002","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0140","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbr.2006.12.004","article-title":"Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease","volume":"178","author":"Dorner","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0145","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2826.2002.00833.x","article-title":"Lack of effect of testosterone and dihydrotestosterone compared to 17beta-oestradiol in 1-methyl-4-phenyl-1,2,3,6, tetrahydropyridine-mice","volume":"14","author":"Ekue","year":"2002","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0150","series-title":"Principles and Practice of Movement Disorders","author":"Fahn","year":"2011"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0160","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0006-8993(03)03198-6","article-title":"Failure of estrogen to protect the substantia nigra pars compacta of female rats from lesion induced by 6-hydroxydopamine","volume":"986","author":"Ferraz","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0155","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/s11064-007-9575-7","article-title":"Evaluation of estrogen neuroprotective effect on nigrostriatal dopaminergic neurons following 6-hydroxydopamine injection into the substantia nigra pars compacta or the medial forebrain bundle","volume":"33","author":"Ferraz","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/jnnp.66.1.52","article-title":"Differences in duration of Huntington's disease based on age at onset","volume":"66","author":"Foroud","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.expneurol.2014.03.010_bb9920","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0306-4522(01)00014-8","article-title":"Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system","volume":"103","author":"Gao","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0006-8993(00)03221-2","article-title":"The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system","volume":"892","author":"Gao","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2014.03.010_bb9910","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00702-003-0045-3","article-title":"Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system","volume":"110","author":"Gajjar","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0175","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1176\/appi.ajgp.12.6.621","article-title":"Pilot study on the effect of estrogen replacement therapy on brain dopamine transporter availability in healthy, postmenopausal women","volume":"12","author":"Gardiner","year":"2004","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.yhbeh.2009.06.002","article-title":"Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: a contribution to sex-specific neuroprotection by estrogens","volume":"57","author":"Gillies","year":"2010","journal-title":"Horm. Behav."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0185","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.neuroscience.2004.12.029","article-title":"Glycogen synthase kinase 3beta links neuroprotection by 17beta-estradiol to key Alzheimer processes","volume":"132","author":"Goodenough","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0190","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1046\/j.1471-4159.1996.66051836.x","article-title":"Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons","volume":"66","author":"Goodman","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0195","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00001756-200002070-00024","article-title":"Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice","volume":"11","author":"Grandbois","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0200","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1023\/A:1011119107765","article-title":"17beta-Estradiol protects against quinolinic acid-induced lipid peroxidation in the rat brain","volume":"15","author":"Heron","year":"2000","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0205","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.expneurol.2009.03.003","article-title":"Anti-aggregation and fibril-destabilizing effects of sex hormones on \u03b1-synuclein fibrils in vitro","volume":"217","author":"Hirohata","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0210","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/mds.23618","article-title":"Tourette syndrome: evolving concepts","volume":"26","author":"Jankovic","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0215","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2826.2005.01337.x","article-title":"Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice","volume":"17","author":"Jourdain","year":"2005","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0220","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/WNL.32.5.547","article-title":"Estrogen treatment of dyskinetic disorders","volume":"32","author":"Koller","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0225","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1212\/WNL.57.8.1519","article-title":"Estrogen, progesterone, and tic severity in women with Gilles de la Tourette syndrome","volume":"57","author":"Kompoliti","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0230","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1210\/endo.138.3.4979","article-title":"Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta","volume":"138","author":"Kuiper","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0235","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3940(99)00815-0","article-title":"Expression of estrogen receptor-alpha and beta mRNA in the developing and adult mouse striatum","volume":"276","author":"Kuppers","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0240","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0006-3223(02)01369-0","article-title":"Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects","volume":"52","author":"Laakso","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2377-10-23","article-title":"Risk of Parkinson's disease after tamoxifen treatment","volume":"10","author":"Latourelle","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0250","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s002590000279","article-title":"Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers","volume":"27","author":"Lavalaye","year":"2000","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0255","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2826.2005.01380.x","article-title":"Influence of oestrogenic compounds on monoamine transporters in rat striatum","volume":"18","author":"Le Saux","year":"2006","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0260","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1056\/NEJM199006073222314","article-title":"Possible exacerbation of tics by androgenic steroids","volume":"322","author":"Leckman","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2014.03.010_bb9080","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neulet.2008.10.011","article-title":"Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice","volume":"448","author":"Lewis","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.expneurol.2014.03.010_bb9880","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/syn.20307","article-title":"Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system","volume":"60","author":"Liu","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0265","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neures.2007.10.005","article-title":"Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease","volume":"60","author":"Liu","year":"2008","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0270","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1212\/WNL.50.4.1141","article-title":"Postmenopausal estrogen use and Parkinson's disease with and without dementia","volume":"50","author":"Marder","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.03.010_bb9870","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000079710","article-title":"Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice","volume":"79","author":"Mickley","year":"2004","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.expneurol.2014.03.010_bb9070","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1021\/cn400132u","article-title":"AC-186, a selective nonsteroidal estrogen receptor beta agonist, shows gender specific neuroprotection in a Parkinson's disease rat model","volume":"4","author":"McFarland","year":"2013","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0275","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1749-6632.1998.tb08230.x","article-title":"The impact of gender and estrogen on striatal dopaminergic neurotoxicity","volume":"844","author":"Miller","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0285","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/jnr.21977","article-title":"Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys","volume":"87","author":"Morissette","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0280","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mce.2008.04.008","article-title":"Estrogen and SERM neuroprotection in animal models of Parkinson's disease","volume":"290","author":"Morissette","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0290","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/mds.23810","article-title":"A preliminary study of finasteride in Tourette syndrome","volume":"26","author":"Muroni","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2014.03.010_bb9860","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0306-4522(02)00578-X","article-title":"Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females","volume":"116","author":"Murray","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2014.03.010_bb9850","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0028-3908(03)00043-1","article-title":"Estrogen, but not testosterone, attenuates methamphetamine-evoked dopamine output from superfused striatal tissue of female and male mice","volume":"44","author":"Myers","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0295","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0006-8993(01)02276-4","article-title":"Chronic estrogen treatment replaces striatal dopaminergic function in ovariectomized rats","volume":"900","author":"Ohtani","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0300","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archneur.63.5.729","article-title":"Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study","volume":"63","author":"Okun","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0305","first-page":"1","article-title":"AC-186 a selective nonsteroidal estrogen receptor agonist, shows gender specific neuroprotection in a Parkinson's disease rat model","author":"Olsson","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0310","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mce.2008.07.019","article-title":"Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice","volume":"296","author":"Ookubo","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0315","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/mds.25076","article-title":"Caffeine and risk of Parkinson's disease in a large cohort of men and women","volume":"27","author":"Palacios","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0320","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/hmg\/ddg270","article-title":"Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families","volume":"12","author":"Pankratz","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0325","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4530(92)90015-Y","article-title":"Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette's syndrome","volume":"17","author":"Peterson","year":"1992","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0330","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1196\/annals.1386.035","article-title":"Estrogen action in neuroprotection and brain inflammation","volume":"1089","author":"Pozzi","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0335","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/mds.870010112","article-title":"Menstrual-related fluctuations in Parkinson's disease","volume":"1","author":"Quinn","year":"1986","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0365","series-title":"Annual Meeting of AAN. Seattle, Washington","article-title":"Role of endogenous and exogenous hormone exposure on the risk of Parkinson's disease","author":"R S-P","year":"2009"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0340","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0169-328X(95)00125-C","article-title":"Effects of sex and estrogen on tyrosine hydroxylase mRNA in cultured embryonic rat mesencephalon","volume":"33","author":"Raab","year":"1995","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0345","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1212\/WNL.62.11.2010","article-title":"Risk of Parkinson disease in women: effect of reproductive characteristics","volume":"62","author":"Ragonese","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.03.010_bb9840","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000070277","article-title":"Repeated estradiol treatment prevents MPTP-induced dopamine depletion in male mice","volume":"77","author":"Ramirez","year":"2003","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0350","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0166-2236(91)90047-X","article-title":"Sexual differentiation of monoaminergic neurons\u2014genetic or epigenetic?","volume":"14","author":"Reisert","year":"1991","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0355","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1212\/01.wnl.0000280573.30975.6a","article-title":"Increased risk of parkinsonism in women who underwent oophorectomy before menopause","volume":"70","author":"Rocca","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0360","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1111\/j.1471-4159.2008.05569.x","article-title":"Gender differences and estrogen effects in parkin null mice","volume":"106","author":"Rodriguez-Navarro","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0370","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/(SICI)1097-4547(19981201)54:5<707::AID-JNR16>3.0.CO;2-T","article-title":"Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death","volume":"54","author":"Sawada","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0375","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0887-8994(92)90051-Y","article-title":"Menstrual cycle-related fluctuations of tics in Tourette syndrome","volume":"8","author":"Schwabe","year":"1992","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0380","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0306-9877(94)90133-3","article-title":"Estrogens and Parkinson's disease","volume":"42","author":"Session","year":"1994","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.expneurol.2014.03.010_bb9150","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.expneurol.2004.08.009","article-title":"Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ERalpha and ERbeta)","volume":"190","author":"Shughrue","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0385","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/mds.22619","article-title":"Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease","volume":"24","author":"Simon","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0390","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.bbagen.2009.11.013","article-title":"Mitochondrial mechanisms of estrogen neuroprotection","volume":"1800","author":"Simpkins","year":"2010","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0395","doi-asserted-by":"crossref","first-page":"e8856","DOI":"10.1371\/journal.pone.0008856","article-title":"Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease","volume":"5","author":"Simunovic","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0400","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jnr.22729","article-title":"Gender segregation in gene expression and vulnerability to oxidative stress induced injury in ventral mesencephalic cultures of dopamine neurons","volume":"90","author":"Tao","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2014.03.010_bb9250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.brainres.2006.02.029","article-title":"Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication","volume":"1084","author":"Tripanichkul","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0405","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1212\/WNL.54.12.2292","article-title":"Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations","volume":"54","author":"Tsang","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0410","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuint.2005.11.011","article-title":"17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats","volume":"48","author":"Tunez","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0415","first-page":"1175","article-title":"Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT","volume":"36","author":"van Dyck","year":"1995","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0420","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1471-4159.2001.00271.x","article-title":"Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells","volume":"77","author":"Wang","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0425","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0006-8993(97)00449-6","article-title":"17beta-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors","volume":"761","author":"Weaver","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0430","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jocn.2011.05.013","article-title":"Gender differences in nigrostriatal dopaminergic innervation are present at young-to-middle but not at older age in normal adults","volume":"19","author":"Wong","year":"2012","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0435","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp.2003.020982","article-title":"Are men at greater risk for Parkinson's disease than women?","volume":"75","author":"Wooten","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0440","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1096\/fj.09-139097","article-title":"Regulation of monoamine oxidase A by the SRY gene on the Y chromosome","volume":"23","author":"Wu","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0445","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1523\/JNEUROSCI.3008-05.2006","article-title":"Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease","volume":"26","author":"Xu","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2014.03.010_bb9350","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s007020070027","article-title":"Estrogen and progesterone distinctively modulate methamphetamine-induced dopamine and serotonin depletions in C57BL\/6J mice","volume":"107","author":"Yu","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2014.03.010_bb0450","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000057337","article-title":"Ovarian hormones do not attenuate methamphetamine-induced dopaminergic neurotoxicity in mice gonadectomized at 4weeks postpartum","volume":"75","author":"Yu","year":"2002","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.expneurol.2014.03.010_bb0455","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.parkreldis.2012.09.012","article-title":"The influence of gender on phenotype and disease progression in patients with Huntington's disease","volume":"19","author":"Zielonka","year":"2013","journal-title":"Parkinsonism Relat. Disord."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488614000879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488614000879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T01:03:28Z","timestamp":1565312608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488614000879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":115,"alternative-id":["S0014488614000879"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2014.03.010","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex differences in Parkinson's disease and other movement disorders","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2014.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}